Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Reaffirmed by Cantor Fitzgerald
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “neutral” rating reissued by analysts at Cantor Fitzgerald in a report released on Monday, Benzinga reports. They currently have a $150.00 price objective on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective indicates a potential downside of 39.42% from the stock’s current price. A number […]
More Stories
The Queen’s Gambit Season 2: When is The Period Drama Releasing?
The American mini-series, The Queen’s Gambit, was one of the most-ranked Netflix content that immediately picked anticipation for a second...
News from the WHO: MeDevIS platform announced to boost access to medical technologies and devices https://ift.tt/zt9r3V5 July 08, 2024 at 07:00AM
Published on July 08, 2024 at 07:00AM View on website
Riverview Bancorp, Inc. (RVSB) To Go Ex-Dividend on July 10th
Riverview Bancorp, Inc. (NASDAQ:RVSB – Get Free Report) declared a quarterly dividend on Wednesday, June 26th, Zacks reports. Stockholders of...
Travis Kelce Getting Emotional On Swift’s Performance Went Viral; Fan Gushes
On Saturday, July 6, a video went viral on the internet wherein the American footballer, Travis Kelce, was seen getting...
The New York Times Company Plans Quarterly Dividend of $0.13 (NYSE:NYT)
The New York Times Company (NYSE:NYT – Get Free Report) announced a quarterly dividend on Thursday, June 27th, RTT News...
Conwest Associates, LP (OTCMKTS:CWPS) Plans Dividend Increase – $1.28 Per Share
Conwest Associates, LP (OTCMKTS:CWPS – Get Free Report) announced a dividend on Saturday, July 6th, investing.com reports. Investors of record...